A kind of tebipenem pivocate granule preparation and preparation method thereof
By controlling the particle size and core particle composition ratio of tebipenempivoferate particles, wet granulation and fluidized bed coating technology are used to optimize the dissolution behavior of the granules, and the inconsistent preparation effects in the existing technology are solved. Problem, a granule preparation with a high bioequivalence to the reference preparation Orapenem is achieved.
Patent Information
- Application Number
- CN202410979628.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-22
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-07-22
AI Technical Summary
During the preparation process of the existing tebipenempivo ester granules, factors such as drug ingredients selection, particle size, auxiliary material dosage and core particle size have a great impact on dissolution behavior, resulting in inconsistent effects, and it is difficult for the existing technology to effectively improve the preparation. bioequivalence.
By controlling the particle size of teipenempivoferate particles, the dosage ratio and particle size of components in the core particles, the core particles are prepared by wet granulation process, and coated through the fluidized bed process to optimize the smell masking layer and coloring correction The composition and coating process of the odor layer result in a granule preparation with similar dissolution behavior as the reference formulation Orapenem.
A highly bioequivalent tebipenempivoferate granule preparation with reference preparation Orapenem was achieved, which significantly improved the stability and dissolution behavior of the preparation and ensured consistency of the efficacy.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of medicines, and particularly relates to a tipopenem pivocate granule preparation and a preparation method thereof. Background Art
[0002] Tebipenem Pivoxil is an oral broad-spectrum carbapenem antibiotic that inhibits the synthesis of bacterial cell walls by binding to bacterial penicillin-binding proteins, achieving a bactericidal effect. The original drug of Tebipenem Pivoxil fine granules was developed by Wyeth Lida Company, with the trade name Orapenem, the specification is 50mg, and the indications include pneumonia, otitis media and sinusitis.
[0003] Chinese invention patent CN113041231A discloses a tebipenem ester fine granule composition and a preparation method thereof, which is composed of three parts: core particles, taste-masking coating layer and colored flavor-correcting coating layer. The raw material is made into core particles by dry granulation technology, and then the taste-masking coating layer and the colored flavor-correcting coating layer are coated by fluidized bed cyclone side spraying process. In addition, the cyclone side spraying process is used for coating the taste-masking coating layer and the colored flavor-correcting coating layer. The invention reduces the loss of coating liquid according to the embedded side spraying, and the coating efficiency is significantly improved. The stability of the prepared tebipenem ester fine granule product is significantly improved, and its quality and efficacy are consistent with the original research.
[0004] Chinese invention patent CN104069072A discloses a granule of a tipipenam-pivodile composition. The granule is composed of the following components by weight: 40 parts of tipipenam-pivodile, 198.7-219.7 parts of sucrose, 5-10 parts of hydroxyethyl methylcellulose, 3-6 parts of cross-linked sodium carboxymethylcellulose, 2-5 parts of phosphatidylethanolamine, 10-20 parts of inositol, 0.1-0.2 parts of sodium ascorbyl palmitate and 0.2-0.5 parts of aspartame. The prepared granule performs well in accelerated tests, long-term tests and antibacterial effect tests.
[0005] At present, there is still room for improvement in the research on tebipenem pivocate granules. Not only the selection of drug ingredients affects the effect of tebipenem pivocate preparations; but also, in the preparation process of tebipenem pivocate granules, the particle size of tebipenem pivocate (API), the amount of excipients, i.e. the ratio, the particle size of the core particles, the preparation method, etc. all have a significant effect on the dissolution behavior of tebipenem pivocate granules. Summary of the invention
[0006] In view of the problems existing in the prior art, the present invention provides a tebipenem pivocate granule preparation and a preparation method thereof. By controlling the particle size of the raw material, the dosage ratio of each component in the core granule, the particle size of the core granule and the preparation method of the tebipenem pivocate granule preparation, a tebipenem pivocate granule preparation having a dissolution behavior similar to that of a reference preparation Orapenem (specification: 50 mg) is obtained.
[0007] To achieve the above purpose, the technical solution adopted by the present invention is as follows:
[0008] In one aspect, the present invention provides a tebipenem pivocate granule preparation, comprising components: a core granule, a taste-masking layer, and a coloring and flavor-correcting layer;
[0009] The core particles include, by mass fraction, 12-16% tipipenam pivoxil, 10-22% microcrystalline cellulose, 0.8-3.5% hydroxypropyl cellulose and 40-55% sucrose;
[0010] The taste masking layer comprises the following components by mass fraction: 1.6-2.4% talc, 0.3-1.6% hydroxypropyl methylcellulose, 2.5-3.8% ethyl cellulose, 2.8-3.8% ethyl acrylate-methyl methacrylate copolymer and 0.4-0.6% triethyl citrate;
[0011] The coloring and flavoring layer includes the following components by mass fraction: 0.8-2% hydroxypropyl methylcellulose, 4-8% sucrose, 2.5-6% aspartame, 0.005-0.02% pigment and 0.5-1% flavor;
[0012] The weight ratio of microcrystalline cellulose to sucrose is 10.67-20:42-53.3;
[0013] The particle size of the tebipenem pivocate is D90=100-210 μm;
[0014] The core particles have a particle size of 40-50 meshes.
[0015] Preferably, the core particles include the following components by mass fraction: 13-15% tipipenam pivoxil, 10.67-20% microcrystalline cellulose, 1-3% hydroxypropyl cellulose and 42-53.33% sucrose;
[0016] The taste masking layer comprises the following components by mass fraction: 1.79-2% talc, 0.35-1.5% hydroxypropyl methylcellulose, 3-3.49% ethyl cellulose, 3-3.49% ethyl acrylate-methyl methacrylate copolymer and 0.5-0.55% triethyl citrate;
[0017] The coloring and flavoring layer includes the following components by mass fraction: 1-1.86% of hydroxypropyl methylcellulose, 4.46-6.99% of sucrose, 3-5% of aspartame, 0.005-0.02% of pigment and 0.5-1% of flavor.
[0018] Further preferably, the core particles include the following components by mass fraction: 13% tipipenam pivoxil, 10.67% microcrystalline cellulose, 3% hydroxypropyl cellulose and 53.33% sucrose;
[0019] The taste masking layer includes the following components by mass fraction: 1.79% talc, 0.35% hydroxypropyl methylcellulose, 3.49% ethyl cellulose, 3.49% ethyl acrylate-methyl methacrylate copolymer and 0.55% triethyl citrate;
[0020] The coloring and flavoring layer includes the following components by mass fraction: 1.86% of hydroxypropyl methylcellulose, 4.46% of sucrose, 3% of aspartame, 0.01% of pigment and 1% of flavor.
[0021] Preferably, the particle size of the tebipenem pivoxil is D90=100-210 μm, and D50=50-105 μm.
[0022] More preferably, the particle size of the tebipenem pivoxil is D90=120-207 μm, and D50=55-102 μm.
[0023] More preferably, the particle size of the tebipenem pivoxil is D90=121-142 μm, and D50=60-80 μm.
[0024] Preferably, the core particles have a particle size of 45 meshes.
[0025] On the other hand, the present invention provides a method for preparing the above-mentioned tipipenam pivoxil granule preparation, specifically a wet granulation method, comprising the steps of:
[0026] (1) Crush the sucrose component in the core particles and set aside;
[0027] (2) Wet granulation:
[0028] (2.1) Premixing: Mix the core granule ingredients of sucrose, tipopenem pivoxil, microcrystalline cellulose and hydroxypropyl cellulose and place them in a wet granulator for premixing;
[0029] (2.2) Add slurry: set the stirring speed to 100-200 rpm, the shear speed to 200-400 rpm, the atomization pressure to 0.15-0.3 bar, the peristaltic pump speed to 40-60 rpm, and add water; the mass of the added water is 55%-85% of the mass of tebipenem pivoxil;
[0030] (2.3) Granulation: Set the stirring speed to 200-400 rpm and the shear speed to 400-600 rpm, perform wet granulation, and dry to obtain dry granules;
[0031] (3) Dry granulation: granulate the dried granules at 400-600 rpm so that all of them pass through a 40-50 mesh sieve to obtain core granules;
[0032] (4) Preparation of taste masking coating liquid:
[0033] (4.1) Ethyl cellulose, ethyl acrylate-methyl methacrylate copolymer and water are mixed, and hydroxypropyl methylcellulose and triethyl citrate are added under stirring, and stirring is continued until dissolved to obtain a taste masking layer coating solution A;
[0034] (4.2) Mix talcum powder and water and homogenize to obtain taste masking coating solution B;
[0035] (4.3) adding the taste-masking layer coating liquid B to the taste-masking layer coating liquid A under stirring to obtain a taste-masking layer coating liquid; the taste-masking layer coating liquid has a solid content of 7-15%;
[0036] (5) Coating and taste-masking layer: preheating the fluidized bed, coating, drying and sieving the core particles to obtain taste-masking layer coated particles;
[0037] (6) Preparation of coloring and flavoring layer coating solution: mixing the coloring and flavoring layer ingredients except aspartame with water to obtain a coloring and flavoring layer coating solution;
[0038] (7) Coating, coloring and flavor correction layer: The taste masking layer coated granules and aspartame are preheated, coated, dried and sieved to obtain tebipenem pivocate granules.
[0039] Preferably, in step (2.1), the particle size of tibipenem pivoxil is D90=100-210 μm, and D50=50-105 μm.
[0040] Further preferably, in step (2.1), the particle size of the tebipenem pivoxil is D90=120-207 μm, and D50=55-102 μm.
[0041] Preferably, the slurrying in step (2.2) is specifically as follows: setting the stirring speed to 150 rpm, the shear speed to 300 rpm, the atomization pressure to 0.2 bar, the peristaltic pump speed to 50 rpm, and adding water; the mass of the added water is 60%-80% of the mass of tebipenem pivoxil.
[0042] Further preferably, the mass of the added water is 70-78% of the mass of tebipenem pivoxil.
[0043] Preferably, the granulation in step (2.3) is specifically as follows: setting the stirring speed to 300 rpm and the shearing speed to 500 rpm; using a 5×5 square hole sieve at 500 rpm for wet granulation; and drying to obtain dry granules.
[0044] Preferably, step (3) is specifically as follows: passing the dried granules through a 1.0 mesh sieve and granulating at 500 rpm so that all of the granules pass through a 45 mesh sieve to obtain core granules.
[0045] Preferably, the homogenization in step (4.2) is performed at 4000-5000 rpm for 7-15 min.
[0046] Further preferably, the homogenization in step (4.2) is specifically homogenization at 4400 rpm for 10 min.
[0047] Preferably, the solid content of the taste masking layer coating liquid in step (4.3) is 9-12%.
[0048] Preferably, in step (5), the coating is specifically as follows: the heater temperature is 55-65°C, the air inlet temperature is 40-50°C, and the fan frequency is 14-18Hz; the liquid supply speed is first 5-8rpm for coating for 4-6min, and then the liquid supply speed is increased to 10-15rpm and continued until all the formulated amount of taste masking coating liquid is sprayed, and the material temperature is maintained at 24-26°C during the granulation process.
[0049] Further preferably, in step (5), the coating is specifically as follows: heater temperature 60°C, air inlet temperature 45°C, fan frequency 16Hz; liquid supply speed: first coating at 8rpm for 5min, then increasing the liquid supply speed to 10rpm and continuing until all the formulated amount of taste masking coating liquid is sprayed, and maintaining the material temperature at 24-26°C during the granulation process.
[0050] Preferably, in step (6), the solid content of the colored flavoring layer coating liquid is 5-10%; further preferably, the solid content of the colored flavoring layer coating liquid is 6-8%.
[0051] Preferably, in step (7), the coating is specifically as follows: placing the taste-masking layer coated particles and aspartame in a fluidized bed, and setting the parameters as follows: heater temperature 70-80°C, air inlet temperature 50-60°C, fan frequency 15-17Hz, atomization pressure 0.1-0.14MPa; liquid supply speed: first coating at 5-7rpm for 5min, then increasing the liquid supply speed to 8-10rpm, and continuing until the formulated amount of the coloring and flavor-correcting layer coating liquid is completely sprayed.
[0052] Further preferably, in step (7), the coating is specifically as follows: placing the taste masking layer coated particles and aspartame in a fluidized bed, and setting the parameters as follows: heater temperature 75°C, air inlet temperature 55°C, fan frequency 16 Hz, atomization pressure 0.12 MPa, liquid supply speed: first coating at 6 rpm for 5 min, then increasing the liquid supply speed to 8 rpm, and continuing until all the formulated amount of the coloring and flavor correction layer coating liquid is sprayed.
[0053] Compared with the prior art, the present invention has the following beneficial effects:
[0054] By controlling the particle size of the raw material, the proportion of the core particle filler and the particle size, the obtained tebipenem pivocate granule preparation has a dissolution behavior similar to that of the reference preparation Orapenem, has a higher similarity factor f2 (f2>50), and achieves a high degree of bioequivalence with the reference preparation. DETAILED DESCRIPTION
[0055] The following non-limiting examples can enable those skilled in the art to more fully understand the present invention, but do not limit the present invention in any way. The following content is merely an exemplary description of the scope of the present invention, and those skilled in the art can make various changes and modifications to the present invention based on the disclosed content, which should also fall within the scope of the present invention.
[0056] When the embodiments give numerical ranges, it should be understood that, unless otherwise specified in the present invention, both endpoints of each numerical range and any numerical value between the two endpoints can be selected. Unless otherwise defined, all technical and scientific terms used in the present invention have the same meanings as those generally understood by those of ordinary skill in the art to which the present invention belongs.
[0057] The present invention is further described below by way of specific examples. The various chemical reagents used in the examples of the present invention are obtained through conventional commercial channels unless otherwise specified. Products from different manufacturers have no significant effect on the effects.
[0058] In the present invention, " / " means that the component is not used or the data does not exist.
[0059] The reference preparation (RLD 02209) used in the present invention is Orapenem (specification: 50 mg) granules of tebipenem and pivocate developed by Japan Meiji Seika Co., Ltd. in the “Catalogue of Reference Preparations for Generic Chemical Drugs (30th Batch)” issued by NMPA.
[0060] Example 1
[0061] A tebipenem pivocitrate granule preparation, the components and mass fraction dosage of which are shown in Table 1:
[0062] Table 1
[0063]
[0064] Example 1 The preparation method of tebipenem pivocitrate granules is shown in Table 2:
[0065] Table 2
[0066]
[0067] The dissolution behavior of the tipipenam-pivobaractone granules obtained in Example 1 in media with different pH values was tested.
[0068] Table 3 shows the comparative results of the dissolution behaviors of the tipipenam pivocitrate granules of Example 1 and the reference preparation in the acetate medium at pH=4.0.
[0069] Table 3
[0070]
[0071] Table 4 shows the comparative results of the dissolution behaviors of the tipipenam pivocitrate granules of Example 1 and the reference preparation in a phosphate medium at pH=5.5.
[0072] Table 4
[0073]
[0074] Table 5 shows the comparative results of the dissolution behaviors of the tipipenam pivocitrate granules of Example 1 and the reference preparation in a pH=6.8 phosphate buffer medium.
[0075] Table 5
[0076]
[0077] Comparative Example 1
[0078] The difference between Comparative Example 1 and Example 1 is that the particle size of the API is different, as shown in Table 6.
[0079] Example 2
[0080] The difference between Example 2 and Example 1 is that the particle size of the API is different, as shown in Table 6.
[0081] Table 6
[0082]
[0083] The dissolution behaviors of the tebipenem pivocitrate granules of Comparative Example 1 and Example 2 and the reference preparation in a pH=6.8 phosphate buffer medium are compared and the results are shown in Table 7.
[0084] Table 7
[0085]
[0086] From the results in Table 7, it can be seen that the particle size of API has a significant effect on the dissolution behavior of the preparation.
[0087] The tebipenem pivocitrate granule preparations with different API particle sizes in Comparative Examples 1-2 and Example 2 were subjected to a mixing uniformity test. The results of the mixing uniformity test are shown in Table 8.
[0088] Table 8
[0089]
[0090] At the same time, the tipipenam pivoxil granule preparations with different API particle sizes in Comparative Example 1-2 and Example 2-1 were subjected to a content uniformity test. The content uniformity test results are shown in Table 9.
[0091] Table 9
[0092]
[0093] Example 3
[0094] Different from Example 1, the components and mass fraction amounts of the tipipenam pivocitrate granule preparation are different, as shown in Table 10 for details.
[0095] Comparative Example 2
[0096] Different from Example 1, the components and mass fraction amounts of the tipipenam pivocitrate granule preparation are different, as shown in Table 10 for details.
[0097] Table 10
[0098]
[0099] The effect of the proportion of fillers in the core granules on the particle size distribution of the tebipenem pivocate granules was investigated. The results of the physical property tests are shown in Table 11:
[0100] Table 11
[0101]
[0102] The physical property inspection results in Table 11 show that in the core particles, when sucrose: microcrystalline cellulose = 42:20 (Example 3), the particle size distribution of the prepared tipopenem pivoxil granule preparation is similar to that of the reference preparation; when sucrose: microcrystalline cellulose = 20:42 (Comparative Example 2), the particle size distribution of the prepared tipopenem pivoxil granule preparation is smaller than that of the reference preparation, and after increasing the proportion of microcrystalline cellulose, the granulation property of the preparation is poor, the overall particle size is small, and there is more powder.
[0103] The dissolution behavior of the preparation of Example 3 was further tested.
[0104] The dissolution behavior comparison results of the tipipenam pivocitrate granules of Example 3 and Comparative Example 2 and the reference preparation in a pH=6.8 phosphate buffer medium are shown in Table 12.
[0105] Table 12
[0106]
[0107] From the dissolution behavior comparison results in Table 12, it can be seen that the f2 of the preparation in Comparative Example 2 is 46, and the f2 of the preparation in Example 3 is 69; after the ratio of sucrose and microcrystalline cellulose was changed in Comparative Example 2, the dissolution of the sample was accelerated, and the dissolution behavior was not similar to that of the reference preparation.
[0108] Comparative Example 3
[0109] The difference from Example 1 is that the core particles have different particle sizes. In the dry granulation step, the specific operation of Comparative Example 3 is: the dry particles are granulated with a 1.0 mesh screen at 500 rpm; and all of them pass through a 30 mesh screen. The rest is the same as Example 1.
[0110] The effect of the proportion of fillers in the core granules on the particle size distribution of the tebipenem pivocate granules was investigated. The results of the physical property tests are shown in Table 13:
[0111] Table 13
[0112]
[0113] As can be seen from Table 13, the particle size distribution of the preparations of Comparative Example 3 and Example 1 is smaller than that of the reference preparation.
[0114] The dissolution behavior of the preparation of Comparative Example 3 was further tested.
[0115] The dissolution behavior comparison results of the tipipenam pivocitrate granules preparation of Comparative Example 3 and the reference preparation in a phosphate medium at pH=5.5 are shown in Table 14.
[0116] Table 14
[0117]
[0118] It can be seen from Table 14 that after the core particles of Comparative Example 3 were passed through 30 mesh and coated with a taste masking layer, the in vitro dissolution behavior of the preparation was different from that of the reference preparation (f2 was 43), and the dissolution of the tebipenem pivocate granules preparation of Comparative Example 3 was incomplete.
[0119] The reason why the core particles dissolve slowly after passing through 30 mesh is that the core particles after passing through 30 mesh have a smaller specific surface area than those after passing through 45 mesh. The coating film of particles with a small surface area will be thicker, thus slowing down the dissolution of the preparation.
[0120] Comparative Example 4
[0121] Different from Example 1, the preparation method of the tebipenem pivocate granules is different. The specific preparation method is shown in Table 15:
[0122] Table 15
[0123]
[0124] The dissolution behavior of the tipipenam pivocitrate granules of Comparative Example 4 was compared with that of the reference preparation. The dissolution behavior comparison results in a phosphate medium with a pH of 5.5 are shown in Table 16.
[0125] Table 16
[0126]
[0127] The core particles of dry granulation have a smaller particle size, which is significantly different from the particle size distribution of the reference preparation. The appearance of the particles is also very different from that of the reference preparation and is needle-shaped, which is not conducive to coating. This will result in a large relative surface area of the coating. Under the same prescription, the coating film is incomplete, resulting in rapid dissolution, and the in vitro dissolution behavior is different from that of the reference preparation.
[0128] The core particles prepared by fluidized bed process were relatively loose, dissolved rapidly in the dissolution medium, and the in vitro dissolution behavior was not similar to that of the reference preparation.
[0129] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.
Claims
1. A granular preparation of tipipenam-pivoxil, characterized in that: The composition includes: core particles, taste masking layer and coloring and flavor correction layer; The core particles include, by mass fraction, 13% tipipenam pivoxil, 10.67% microcrystalline cellulose, 3% hydroxypropyl cellulose and 53.33% sucrose; The taste masking layer includes the following components by mass fraction: 1.79% talc, 0.35% hydroxypropyl methylcellulose, 3.49% ethyl cellulose, 3.49% ethyl acrylate-methyl methacrylate copolymer and 0.55% triethyl citrate; The coloring and flavoring layer includes the following components by mass fraction: 1.86% hydroxypropyl methylcellulose, 4.46% sucrose, 3% aspartame, 0.01% pigment and 1% flavor; The particle size of the tebipenem pivoxil is D90=100-210 μm, D50=50-105 μm; The core particles have a particle size of 40-50 mesh; The preparation method of the tebipenem pivocitrate granule preparation is a wet granulation method, comprising the steps of: (1) Crush the sucrose component in the core particles and set aside; (2) Wet granulation: (2.1) Premixing: Mix the core granule ingredients of sucrose, tipopenem pivoxil, microcrystalline cellulose and hydroxypropyl cellulose and place them in a wet granulator for premixing; (2.2) Add slurry: set the stirring speed to 100-200 rpm, the shear speed to 200-400 rpm, the atomization pressure to 0.15-0.3 bar, the peristaltic pump speed to 40-60 rpm, and add water; the mass of the added water is 55%-85% of the mass of tebipenem pivoxil; (2.3) Granulation: Set the stirring speed to 200-400 rpm and the shear speed to 400-600 rpm, perform wet granulation, and dry to obtain dry granules; (3) Dry granulation: granulate the dried granules at 400-600 rpm so that all of them pass through a 40-50 mesh sieve to obtain core granules; (4) Preparation of taste masking coating liquid: (4.1) Ethyl cellulose, ethyl acrylate-methyl methacrylate copolymer and water are mixed, and hydroxypropyl methylcellulose and triethyl citrate are added under stirring, and stirring is continued until dissolved to obtain a taste masking layer coating solution A; (4.2) Mix talcum powder and water and homogenize to obtain taste masking coating solution B; (4.3) adding the taste-masking layer coating liquid B to the taste-masking layer coating liquid A under stirring to obtain a taste-masking layer coating liquid; the taste-masking layer coating liquid has a solid content of 7-15%; (5) Coating and taste-masking layer: preheating the fluidized bed, coating, drying and sieving the core particles to obtain taste-masking layer coated particles; (6) Preparation of coloring and flavoring layer coating solution: Mix the coloring and flavoring layer ingredients except aspartame with water to obtain a coloring and flavoring layer coating solution; (7) Coating, coloring and flavoring layer: The taste-masking layer coated granules and aspartame are preheated, coated, dried and sieved to obtain tebipenem pivocate granules.
2. The tebipenem pivocitrate granule preparation according to claim 1, characterized in that: The core particles have a particle size of 45 meshes.
3. The method for preparing the tipipenam-pivodile granules according to any one of claims 1 to 2, characterized in that: The preparation method is a wet granulation method, characterized in that it comprises the steps of: (1) Crush the sucrose component in the core particles and set aside; (2) Wet granulation: (2.1) Premixing: Mix the core granule ingredients of sucrose, tipopenem pivoxil, microcrystalline cellulose and hydroxypropyl cellulose and place them in a wet granulator for premixing; (2.2) Add slurry: set the stirring speed to 100-200 rpm, the shear speed to 200-400 rpm, the atomization pressure to 0.15-0.3 bar, the peristaltic pump speed to 40-60 rpm, and add water; the mass of the added water is 55%-85% of the mass of tebipenem pivoxil; (2.3) Granulation: Set the stirring speed to 200-400 rpm and the shear speed to 400-600 rpm, perform wet granulation, and dry to obtain dry granules; (3) Dry granulation: granulate the dried granules at 400-600 rpm so that all of them pass through a 40-50 mesh sieve to obtain core granules; (4) Preparation of taste masking coating liquid: (4.1) Ethyl cellulose, ethyl acrylate-methyl methacrylate copolymer and water are mixed, and hydroxypropyl methylcellulose and triethyl citrate are added under stirring, and stirring is continued until dissolved to obtain a taste masking layer coating solution A; (4.2) Mix talcum powder and water and homogenize to obtain taste masking coating solution B; (4.3) adding the taste-masking layer coating liquid B to the taste-masking layer coating liquid A under stirring to obtain a taste-masking layer coating liquid; the taste-masking layer coating liquid has a solid content of 7-15%; (5) Coating and taste-masking layer: preheating the fluidized bed, coating, drying and sieving the core particles to obtain taste-masking layer coated particles; (6) Preparation of coloring and flavoring layer coating solution: Mix the coloring and flavoring layer ingredients except aspartame with water to obtain a coloring and flavoring layer coating solution; (7) Coating, coloring and flavoring layer: The taste-masking layer coated granules and aspartame are preheated, coated, dried and sieved to obtain tebipenem pivocate granules.
4. The preparation method according to claim 3, characterized in that: The slurrying in step (2.2) is specifically as follows: setting the stirring speed to 150 rpm, the shear speed to 300 rpm, the atomization pressure to 0.2 bar, the peristaltic pump speed to 50 rpm, and adding water; the mass of the added water is 60%-80% of the mass of tebipenem pivoxil; The granulation in step (2.3) is specifically as follows: setting the stirring speed to 300 rpm and the shearing speed to 500 rpm; using a 5×5 square hole sieve at 500 rpm for wet granulation; drying to obtain dry granules; Step (3) specifically comprises: passing the dried granules through a 1.0 mesh sieve and granulating at 500 rpm so that all of the granules pass through a 45 mesh sieve to obtain core granules; The homogenization described in step (4.2) is specifically homogenization at 4000-5000 rpm for 7-15 minutes; The solid content of the taste masking coating liquid in step (4.3) is 9-12%; In step (5), the coating is specifically as follows: the heater temperature is 55-65°C, the air inlet temperature is 40-50°C, and the fan frequency is 14-18Hz; the liquid supply speed is first 5-8rpm for coating for 4-6min, and then the liquid supply speed is increased to 10-15rpm and continued until all the taste masking coating liquid of the formula amount is sprayed, and the material temperature is maintained at 24-26°C during the granulation process; In step (6), the solid content of the coloring and flavoring layer coating liquid is 5-10%; In step (7), the coating is specifically as follows: placing the taste masking layer coated particles and aspartame in a fluidized bed, and setting the parameters as follows: heater temperature 70-80°C, air inlet temperature 50-60°C, fan frequency 15-17Hz, atomization pressure 0.1-0.14MPa; liquid supply speed: first coating at 5-7rpm for 5min, then increasing the liquid supply speed to 8-10rpm, and continuing until all the formulated amount of the coloring and flavor correction layer coating liquid is sprayed.
5. The preparation method according to claim 4, characterized in that: In step (2.2), the mass of the added water is 70-78% of the mass of tebipenem pivoxil; The homogenization described in step (4.2) is specifically homogenization at 4400 rpm for 10 min; In step (5), the coating is specifically as follows: heater temperature 60°C, air inlet temperature 45°C, fan frequency 16Hz; liquid supply speed: first 8rpm for 5min, then increase the liquid supply speed to 10rpm, and continue until all the taste masking coating liquid of the formula is sprayed, and the material temperature is maintained at 24-26°C during the granulation process; In step (6), the solid content of the coloring and flavoring layer coating liquid is 6-8%; In step (7), the coating is specifically as follows: placing the taste masking layer coated particles and aspartame in a fluidized bed, and setting the parameters as follows: heater temperature 75°C, air inlet temperature 55°C, fan frequency 16 Hz, atomization pressure 0.12 MPa, liquid supply speed: first coating at 6 rpm for 5 minutes, then increasing the liquid supply speed to 8 rpm and continuing until all the formulated amount of the color masking and flavor correction layer coating liquid is sprayed.
Citation Information
Patent Citations
Tebipenam pivoxil composite granule
CN104069072A
Tebipenem pivoxil fine granule composition and preparation method thereof
CN113041231A
Tebipenem pivoxil granule composition as well as preparation method and application thereof
CN105193742A
Preparation method of fine tebipenem pivoxil granules
CN109432044A
Prescription composition of tebipenem pivoxil fine granules and preparation process of tebipenem pivoxil fine granules
CN114652701A
